Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 717598, 5 pages
http://dx.doi.org/10.1155/2014/717598
Clinical Study

Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience

1Department of Ophthalmology, University Hospital of León, 24071 León, Spain
2Uveitis Unit, University Hospital of León, 24071 León, Spain
3Institute of Biomedicine (INBIOMED), University of León, León, Spain
4Department of Rheumatology, University Hospital “Marques de Valdecilla”, IFIMAV, 39008 Santander, Spain
5Department of Ophthalmology, University Hospital “Clínic”, 08036 Barcelona, Spain
6Department of Rheumatology, University Hospital of León, 24071 León, Spain
7Department of Immunology, University Hospital of León, 24071 León, Spain

Received 9 March 2014; Revised 25 April 2014; Accepted 12 May 2014; Published 28 May 2014

Academic Editor: Dennis Daniel Taub

Copyright © 2014 Miguel Cordero-Coma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Miguel Cordero-Coma, Vanesa Calvo-Río, Alfredo Adán, et al., “Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience,” Mediators of Inflammation, vol. 2014, Article ID 717598, 5 pages, 2014. https://doi.org/10.1155/2014/717598.